{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:11:40Z","timestamp":1788793900661,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002680"],"award-info":[{"award-number":["82002680"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["YQ2024H012"],"award-info":[{"award-number":["YQ2024H012"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program for Young Talents of Basic Research in Universities of Heilongjiang Province","award":["2024127"],"award-info":[{"award-number":["2024127"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08714-w","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:16:08Z","timestamp":1785320168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancer-mediated DDIT4 activation by SMYD2-dependent H3K4me1 promotes pazopanib resistance in clear cell renal cell carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Yun","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beichen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"8714_CR1","doi-asserted-by":"publisher","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics, 2026. CA Cancer J Clin. 2026;76(e70043). https:\/\/doi.org\/10.3322\/caac.70043.","DOI":"10.3322\/caac.70043"},{"key":"8714_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cancergen.2025.02.004","volume":"292\u2013293","author":"D Kawahara","year":"2025","unstructured":"Kawahara D, Kishi M, Kadooka Y, Hirose K, Murakami Y. Integrating radiomics and gene expression by mapping on the image with improved DeepInsight for clear cell renal cell carcinoma. Cancer Genet. 2025;292\u2013293:100\u20135. https:\/\/doi.org\/10.1016\/j.cancergen.2025.02.004.","journal-title":"Cancer Genet"},{"key":"8714_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","volume":"87","author":"A Bex","year":"2025","unstructured":"Bex A, Ghanem YA, Albiges L, Bonn S, Campi R, Capitanio U, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update. Eur Urol. 2025;87:683\u201396. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.020.","journal-title":"Eur Urol"},{"key":"8714_CR4","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.str.2011.06.011","volume":"19","author":"AD Ferguson","year":"2011","unstructured":"Ferguson AD, Larsen NA, Howard T, Pollard H, Green I, Grande C, et al. Structural Basis of Substrate Methylation and Inhibition of SMYD2. Structure. 2011;19:1262\u201373. https:\/\/doi.org\/10.1016\/j.str.2011.06.011.","journal-title":"Structure"},{"key":"8714_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41421-023-00644-x","volume":"10","author":"AG Casanova","year":"2024","unstructured":"Casanova AG, Roth GS, Hausmann S, Lu X, Bischoff LJM, Froeliger EM, et al. Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis. Cell Discovery Nat Publishing Group. 2024;10:12. https:\/\/doi.org\/10.1038\/s41421-023-00644-x.","journal-title":"Cell Discovery Nat Publishing Group"},{"key":"8714_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cell.2011.01.024","volume":"144","author":"M Bulger","year":"2011","unstructured":"Bulger M, Groudine M. Functional and Mechanistic Diversity of Distal Transcription Enhancers. Cell. 2011;144:327\u201339. https:\/\/doi.org\/10.1016\/j.cell.2011.01.024.","journal-title":"Cell"},{"key":"8714_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ng1966","volume":"39","author":"ND Heintzman","year":"2007","unstructured":"Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet Nat Publishing Group. 2007;39:311\u20138. https:\/\/doi.org\/10.1038\/ng1966.","journal-title":"Nat Genet Nat Publishing Group"},{"key":"8714_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10456-022-09839-4","volume":"26","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhou L, Xu Y, Zhou J, Jiang T, Wang J, et al. Targeting SMYD2 inhibits angiogenesis and increases the efficiency of apatinib by suppressing EGFL7 in colorectal cancer. Angiogenesis Springer. 2022;26:1\u201318. https:\/\/doi.org\/10.1007\/s10456-022-09839-4.","journal-title":"Angiogenesis Springer"},{"key":"8714_CR9","doi-asserted-by":"publisher","first-page":"114174","DOI":"10.1016\/j.celrep.2024.114174","volume":"43","author":"R Blawski","year":"2024","unstructured":"Blawski R, Vokshi BH, Guo X, Kittane S, Sallaku M, Chen W, et al. Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer. Cell Rep. 2024;43:114174. https:\/\/doi.org\/10.1016\/j.celrep.2024.114174.","journal-title":"Cell Rep"},{"key":"8714_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41419-021-04483-0","volume":"13","author":"Y Yu","year":"2022","unstructured":"Yu Y, Thonn V, Patankar JV, Thoma O-M, Waldner M, Zielinska M, et al. SMYD2 targets RIPK1 and restricts TNF-induced apoptosis and necroptosis to support colon tumor growth. Cell Death Disease Nat Publishing Group. 2022;13:52. https:\/\/doi.org\/10.1038\/s41419-021-04483-0.","journal-title":"Cell Death Disease Nat Publishing Group"},{"key":"8714_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41388-024-02945-1","volume":"43","author":"J Li","year":"2024","unstructured":"Li J, Hong Z, Zhang J, Zheng S, Wan F, Liu Z, et al. Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide. Oncogene Nat Publishing Group. 2024;43:744\u201357. https:\/\/doi.org\/10.1038\/s41388-024-02945-1.","journal-title":"Oncogene Nat Publishing Group"},{"key":"8714_CR12","doi-asserted-by":"publisher","first-page":"8377","DOI":"10.7150\/thno.37628","volume":"9","author":"L Yan","year":"2019","unstructured":"Yan L, Ding B, Liu H, Zhang Y, Zeng J, Hu J, et al. Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma. Theranostics. 2019;9:8377\u201391. https:\/\/doi.org\/10.7150\/thno.37628.","journal-title":"Theranostics"},{"key":"8714_CR13","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s12276-023-00987-1","volume":"55","author":"K Kim","year":"2023","unstructured":"Kim K, Ryu TY, Jung E, Han T-S, Lee J, Kim S-K, et al. Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis. Experimental Mol Med Nat Publishing Group. 2023;55:952\u201364. https:\/\/doi.org\/10.1038\/s12276-023-00987-1.","journal-title":"Experimental Mol Med Nat Publishing Group"},{"key":"8714_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-70601-1","author":"YK Choi","year":"2026","unstructured":"Choi YK, Lee D-K, Park M, Byeon J, Nam W-Y, Lai TL, et al. The REDD1\u2013NF-\u03baB\u2013miRNAs\u2013eNOS\/SIRT1 axis mediates obesity-induced endothelial cell senescence and hypertension. Nat Commun [Internet] Nat. 2026. https:\/\/doi.org\/10.1038\/s41467-026-70601-1. Publishing Group.","journal-title":"Nat Commun [Internet] Nat"},{"key":"8714_CR15","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/s41375-022-01609-x","volume":"36","author":"V Barroca","year":"2022","unstructured":"Barroca V, Henry E, Dechamps N, Renou L, Chaintreuil P, Kulkarni R, et al. REDD1 is a gatekeeper of murine hematopoietic stem cell functions during stress responses. Leuk Nat Publishing Group. 2022;36:2140\u20133. https:\/\/doi.org\/10.1038\/s41375-022-01609-x.","journal-title":"Leuk Nat Publishing Group"},{"key":"8714_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41419-025-07396-4","volume":"16","author":"S Sunilkumar","year":"2025","unstructured":"Sunilkumar S, Subrahmanian SM, Yerlikaya EI, Toro AL, Harhaj EW, Kimball SR, et al. REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy. Cell Death Disease Nat Publishing Group. 2025;16:79. https:\/\/doi.org\/10.1038\/s41419-025-07396-4.","journal-title":"Cell Death Disease Nat Publishing Group"},{"key":"8714_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41416-018-0368-3","volume":"120","author":"M Foltyn","year":"2019","unstructured":"Foltyn M, Luger A-L, Lorenz NI, Sauer B, Mittelbronn M, Harter PN, et al. The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma. Br J Cancer Nat Publishing Group. 2019;120:481\u20137. https:\/\/doi.org\/10.1038\/s41416-018-0368-3.","journal-title":"Br J Cancer Nat Publishing Group"},{"key":"8714_CR18","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s10495-019-01559-3","volume":"24","author":"N Mu","year":"2019","unstructured":"Mu N, Lei Y, Wang Y, Wang Y, Duan Q, Ma G, et al. Inhibition of SIRT1\/2 upregulates HSPA5 acetylation and induces pro-survival autophagy via ATF4-DDIT4-mTORC1 axis in human lung cancer cells. Apoptosis Springer. 2019;24:798\u2013811. https:\/\/doi.org\/10.1007\/s10495-019-01559-3.","journal-title":"Apoptosis Springer"},{"key":"8714_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40880-018-0315-y","volume":"38","author":"F Du","year":"2018","unstructured":"Du F, Sun L, Chu Y, Li T, Lei C, Wang X, et al. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways. Cancer Commun Am Association Advancement Sci. 2018;38:45. https:\/\/doi.org\/10.1186\/s40880-018-0315-y.","journal-title":"Cancer Commun Am Association Advancement Sci"},{"key":"8714_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13000-018-0754-4","volume":"13","author":"B Chang","year":"2018","unstructured":"Chang B, Meng J, Zhu H, Du X, Sun L, Wang L, et al. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma. Diagn Pathol BioMed Cent. 2018;13:87. https:\/\/doi.org\/10.1186\/s13000-018-0754-4.","journal-title":"Diagn Pathol BioMed Cent"},{"key":"8714_CR21","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1158\/1078-0432.CCR-17-0419","volume":"24","author":"Q Zeng","year":"2018","unstructured":"Zeng Q, Liu J, Cao P, Li J, Liu X, Fan X, et al. Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy. Clin Cancer Res. 2018;24:445\u201359. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0419.","journal-title":"Clin Cancer Res"},{"key":"8714_CR22","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s41467-019-09982-5","volume":"10","author":"HS Kaya-Okur","year":"2019","unstructured":"Kaya-Okur HS, Wu SJ, Codomo CA, Pledger ES, Bryson TD, Henikoff JG, et al. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat Commun. 2019;10:1930. https:\/\/doi.org\/10.1038\/s41467-019-09982-5.","journal-title":"Nat Commun"},{"key":"8714_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cancergen.2025.03.005","volume":"294\u2013295","author":"T Okamoto","year":"2025","unstructured":"Okamoto T, Mizuta R, Demachi-Okamura A, Muraoka D, Sasaki E, Masago K, et al. Immune prognostic model for glioblastoma based on the ssGSEA enrichment score. Cancer Genet. 2025;294\u2013295:32\u201341. https:\/\/doi.org\/10.1016\/j.cancergen.2025.03.005.","journal-title":"Cancer Genet"},{"key":"8714_CR24","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1038\/s41467-024-52375-6","volume":"15","author":"BS Perlman","year":"2024","unstructured":"Perlman BS, Burget N, Zhou Y, Schwartz GW, Petrovic J, Modrusan Z, et al. Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance. Nat Commun Nat Publishing Group. 2024;15:8070. https:\/\/doi.org\/10.1038\/s41467-024-52375-6.","journal-title":"Nat Commun Nat Publishing Group"},{"key":"8714_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-025-02170-6","volume":"10","author":"S Ma","year":"2025","unstructured":"Ma S, Wang Z, Xiong Z, Ge Y, Xu M-Y, Zhang J, et al. Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer. Signal Transduction and Targeted Therapy. Nat Publishing Group. 2025;10:87. https:\/\/doi.org\/10.1038\/s41392-025-02170-6.","journal-title":"Nat Publishing Group"},{"key":"8714_CR26","doi-asserted-by":"publisher","unstructured":"Yang Z, Hu Y, Yang C, Li Y, Zhong X, Wu Z, et al. SMYD2-mediated methylation of STAT1 protects against hepatic ischaemia\/reperfusion injury by blocking JAK-STAT1 signalling pathways. BMJ Publishing Group; 2026. https:\/\/doi.org\/10.1136\/gutjnl-2025-336400.","DOI":"10.1136\/gutjnl-2025-336400"},{"key":"8714_CR27","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.omtn.2022.08.029","volume":"29","author":"C Bao","year":"2022","unstructured":"Bao C, Duan J, Xie Y, Liu Y, Li P, Li J, et al. A novel oncogenic enhancer of estrogen receptor-positive breast cancer. Mol Therapy - Nucleic Acids. 2022;29:836\u201351. https:\/\/doi.org\/10.1016\/j.omtn.2022.08.029.","journal-title":"Mol Therapy - Nucleic Acids"},{"key":"8714_CR28","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.1038\/s41467-022-35469-x","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Zhang L, You W, Xu J, Dai J, Hua D, et al. PRDM1\/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells. Nat Commun Nat Publishing Group. 2022;13:7677. https:\/\/doi.org\/10.1038\/s41467-022-35469-x.","journal-title":"Nat Commun Nat Publishing Group"},{"key":"8714_CR29","doi-asserted-by":"publisher","unstructured":"Xu S, Hong J, Dongye M, Lin J, Xue R, Huang Z et al. The synergistic effect of c-Myb hyperactivation and Pu.1 deficiency induces Pelger\u2013Hu\u00ebt anomaly and promotes sAML. Proceedings of the National Academy of Sciences. Proceedings of the National Academy of Sciences; 2025;122:e2416121122. https:\/\/doi.org\/10.1073\/pnas.2416121122","DOI":"10.1073\/pnas.2416121122"},{"key":"8714_CR30","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1158\/0008-5472.CAN-16-1306","volume":"76","author":"R Wu","year":"2016","unstructured":"Wu R, Nie Q, Tapper EE, Jerde CR, Dunlap GS, Shrestha S, et al. Histone H3K27 Trimethylation Modulates 5-Fluorouracil Resistance by Inhibiting PU.1 Binding to the DPYD Promoter. Cancer Res. 2016;76:6362\u201373. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1306.","journal-title":"Cancer Res"},{"key":"8714_CR31","doi-asserted-by":"publisher","first-page":"103836","DOI":"10.1016\/j.redox.2025.103836","volume":"86","author":"K Zhang","year":"2025","unstructured":"Zhang K, Zhao Y, Chen X, Li Y, Lan T, Chang M, et al. p53 promote oxidative stress, neuroinflammation and behavioral disorders via DDIT4-NF-\u03baB signaling pathway. Redox Biol. 2025;86:103836. https:\/\/doi.org\/10.1016\/j.redox.2025.103836.","journal-title":"Redox Biol"},{"key":"8714_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.canlet.2014.12.033","volume":"358","author":"Y Wang","year":"2015","unstructured":"Wang Y, Han E, Xing Q, Yan J, Arrington A, Wang C, et al. Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells. Cancer Lett. 2015;358:170\u20139. https:\/\/doi.org\/10.1016\/j.canlet.2014.12.033.","journal-title":"Cancer Lett"},{"key":"8714_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-026-08648-7","author":"R Mora-Molina","year":"2026","unstructured":"Mora-Molina R, El Yousfi Y, Hagenlocher C, Fern\u00e1ndez-Farr\u00e1n FJ, Rehm M, Palacios C, et al. REDD1\/DDIT4 counteracts endoplasmic reticulum stress-induced apoptosis by controlling the expression of death receptor TRAILR2\/DR5 in cancer cells. Cell Death Disease Nat Publishing Group. 2026. https:\/\/doi.org\/10.1038\/s41419-026-08648-7. [cited 2026 Apr 22].","journal-title":"Cell Death Disease Nat Publishing Group"},{"key":"8714_CR34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cancergen.2025.07.009","volume":"296\u2013297","author":"Q Wei","year":"2025","unstructured":"Wei Q, Yang Y, Wang H, Li C, Li Y. The mechanism of lncRNA SSTR5-AS1 promoting ferroptosis resistance and immune escape in ovarian cancer cells by recruiting STAT3 to regulate SLC7A11 expression. Cancer Genet. 2025;296\u2013297:172\u201381. https:\/\/doi.org\/10.1016\/j.cancergen.2025.07.009.","journal-title":"Cancer Genet"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08714-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08714-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08714-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:00:37Z","timestamp":1788793237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08714-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8714"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08714-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were conducted in accordance with institutional guidelines and approved by the Animal Care and Ethics Committee of the First Affiliated Hospital of Harbin Medical University (IACUC approval number: 2023141). Human RCC tissue microarrays were obtained from Outdo Biotech Co., Ltd. (Shanghai, China). The use of these specimens was approved by the Ethics Committee of Outdo Biotech Co., Ltd. (approval number: SHYJS-CP-1510001), and informed consent was obtained from all patients.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1150"}}